Posttraumatic Stress Disorder (PTSD) is a major public health challenge made increasingly more significant as Service Members return from recent conflicts in the Middle East. While effective treatments are available, a significant number of patients remain symptomatic or are unable to utilize these treatments to their full potential. Thus, additional development and treatment optimization is essential. Isolating efficacious components of treatment and empirically testing them requires multiple studies and large numbers of subjects, and thus, is prohibitively expensive. Research on mechanisms of treatment response can inform improvements in treatment development and practice. Integrating affective neuroscience methods, such as identifying candidate peripheral biomarkers, into treatment trials can make each study more informative and effective.
Dr. Rauch discusses methodology of how to integrate biomarkers measures into clinical trials and critical elements of design required to inform interpretation of results. She also presents results across several of her translational treatment outcomes trials examining potential biomarkers of PTSD and PTSD treatment mechanisms.
ADAA Continuing Education Credits for Live and On-Demand Programming
Learners complete an evaluation form to receive a certificate of completion. You must participate in the entire activity as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Some ADAA professional webinars focused on diversity or cultural competency subject matter are eligible for the Cross-Culture Competency Diversity Credit. If a webinar is eligible for this credit, it will be reflected on your credit certificate.
All continuing education credits are provided through Amedco, LLC. Learn more about the CE/CME accreditation information here.